• Home
  • NEW DAY MEDICINE
  • 1 (33) 2021
  • 76 -1 (33) 2021 — Ibadova M.U., Tulaboeva G.M., — INDICATORS OF BASAL AND POST-LOADING GLYCEMIA IN PATIENTS WITH VARIOUS MANIFESTATIONS OF CORONARY HEART DISEASE

76 -1 (33) 2021 — Ibadova M.U., Tulaboeva G.M., — INDICATORS OF BASAL AND POST-LOADING GLYCEMIA IN PATIENTS WITH VARIOUS MANIFESTATIONS OF CORONARY HEART DISEASE

INDICATORS OF BASAL AND POST-LOADING GLYCEMIA IN PATIENTS WITH VARIOUS MANIFESTATIONS OF CORONARY HEART DISEASE

Ibadova M.U., Center for the Development of Professional Qualifications of Medical Workers

Tulaboeva G.M., Center for the Development of Professional Qualifications of Medical Workers

Khatamova D.T., Center for the Development of Professional Qualifications of Medical Workers

Nuritdinov Sh.F.,  Center for the Development of Professional Qualifications of Medical Workers

Nurmuxamedova D.E. Center for the Development of Professional Qualifications of Medical Workers

Resume

The state of glycemia in patients with various clinical forms of CHD was studied. A total of 135 male patients aged 30-69 years suffering from coronary heart disease were examined. For the diagnosis of CHD, a survey and instrumental methods of research were used. The survey was conducted according to the standard WHO questionnaire to identify stable angina and possibly myocardial infarction. The ECG data were analyzed according to the Minnesota code. The following clinical forms of CHD were studied: a previous myocardial infarction, stable angina, pain-free myocardial ischemia, a possible history of myocardial infarction, and possible CHD according to ECG data. The level of glycemia was studied on the standard glucose tolerance test (GTT). Fasting glycemic levels were studied, as well as one and two hours after taking 75 g of glucose.

Established differences in the levels of basal and post-loading glycemia in various clinical forms of CHD. These data, to a certain extent, are associated with the literature data that the typical clinical picture of CHD changes under conditions of hyperglycemia. At the same time, the results of the study indicate that hyperglycemia is associated with a more severe form of CHD (a previous myocardial infarction) and an atypical course of this disease.

Keywords: coronary heart disease, pain-free myocardial ischemia, metabolic syndrome, glycemia, impaired glucose tolerance.

First page

399

Last page

403

For citation:Ibadova M.U., Tulaboeva G.M., Khatamova D.T., Nuritdinov Sh.F.,  Nurmuxamedova D.E. Indicators of basal and post-loading glycemia in patients with various manifestations of coronary heart disease//New Day in Medicine 1(33)2021 399-403 https://cutt.ly/ZbyJlZH

LIST OF REFERENCES

  1. Postanovlenie Prezidenta Respubliki Uzbekistan №PP-4063 «O merah po profilaktike neinfekcionnyh zabolevanij, podderzhke zdorovogo obraza zhizni i po-vysheniyu urovnya fizicheskoj aktivnosti naseleniya» ot 18 dekabrya 2018 goda.
  2. Hans Henri P Kluge. Prevention and control of non-communicable diseases in the COVID-19 response / The Lancet. VOLUME 395, ISSUE 10238, P1678-1680, MAY 30, 2020. DOI:https://doi.org/10.1016/S0140-6736(20)31067-9.
  3. Noncommunicable diseases country profiles 2018. Geneva: World Health Organization; 2018. Licence: CC BY-NC-SA 3.0 IGO.
  4. Xia Li, Chuqing Cao, Xiaohan Tang et al. Prevalence of Metabolic Syndrome and Its Determinants in Newly-Diagnosed Adult-Onset Diabetes in China: A Multi-Center, Cross-Sectional Survey / Front Endocrinol (Lausanne). 2019; 10: 661. doi: 10.3389/fendo.2019.00661
  5. Kayumov U.K., Kalandarova U.A., Ibragimov A.Yu., Saipova M.L. The prevalence of ischemic heart disease and mortality from this disease at various components of metabolic syndrome / New day in medicine. 2019, 3 (27), 138-141
  6. Kayumov U.K., Sushinsky V.E., Kalandarova U.A., Ibadova M.U., Saipova M.L. Relationship of asymptomatic hyperuricemia with some components of metabolic syndrome and hemic heart disease // Eurasian Bulletin of Pediatrics. – 2019; 3 (3): 155-161. https://cutt.ly/EcBc7Cm
  7. Abduhakimova N.A., Hatamova D.T., Kayumov U.K. CHastota i urovni nekotoryh osnovnyh komponentov metabolicheskogo sindroma u bol’nyh podagroj pri saharnom diabete i narushennoj tolerantnosti k glyukoze/ Vrach-aspirant. 2009, 3, S.182-186.
  8. Kalandarova U.A., Ibadova M.U., Kayumov N.U., Ismatova M.N. Dinamika urovnej komponentov metabolicheskogo sindroma pri razlichnyh vidah giperglikemii // ZHurnal biomediciny i praktiki. – Tashkent, 2019. -№1. – S.74-78. (14.00.00, №24).
  9. Ferrannini, Giulia et al “Is Coronary Artery Disease Inevitable in Type 2 Diabetes? From a Glucocentric to a Holistic View on Patient Management.” Diabetes Care 43.9 (2020): 2001-2009. Web. 27 April. 2021.
  10. Cai X, Zhang Y, Li M, Wu J H, Mai L, Li J et al. Association between prediabetes and risk of all cause mortality and cardiovascular disease: updated meta-analysis BMJ 2020; 370 :m2297 doi:10.1136/bmj.m2297

file

download